He Shou Wu and Hair Loss in 2026: Does the Science Match the Hype?

He Shou Wu (Polygonum multiflorum) hits androgenetic alopecia through at least four distinct biological pathways — and new research is finally explaining why a root used in Chinese medicine for over a millennium keeps showing up in serious hair-loss conversations. The catch: it carries a real liver-injury risk that any honest assessment has to address head-on.

Four Mechanisms, One Root

Most conventional hair-loss treatments own a single lane. Finasteride blocks 5α-reductase to lower DHT [5]. Minoxidil dilates scalp vasculature [4]. He Shou Wu appears to work across multiple axes simultaneously — which is either its greatest strength or a convenient story, depending on how much you trust the underlying data.

A 2026 review in the Journal of Holistic Integrative Pharmacy synthesized preclinical and clinical evidence into four core mechanisms [1]:

• DHT attenuation — extracts suppress androgen receptor expression in dermal papilla cells and blunt DHT-induced follicle miniaturization, without necessarily reducing systemic DHT production [1][14]
• Wnt/β-catenin + Shh activation — topical application in rodent models shifted follicles from telogen to anagen while increasing β-catenin expression and suppressing DKK-1, a Wnt antagonist up-regulated by DHT [1]
• Anti-apoptotic support — in cultured human dermal papilla cells, PM extract up-regulated Bcl-2 and down-regulated BAD, shifting follicular cells toward survival rather than premature death [1]
• Scalp microcirculation — stilbene glycosides (notably TSG) improve endothelial function via anti-oxidant pathways, potentially delivering better follicular nutrition without the hemodynamic side effects of oral minoxidil [3]

Network pharmacology docking studies add further detail: ligands including emodin, chrysophanol, and resveratrol bind HRAS, PIK3CA, and PIK3CB at energies below −9 kcal/mol, implicating PI3K/Akt and apoptosis regulation [3]. That's mechanistically interesting, though in silico data don't equal clinical outcomes.

For context on how He Shou Wu fits into a broader hair restoration treatment protocol, the multi-pathway model is genuinely distinct from standard monotherapy — and worth understanding before adding it to a stack.

What the Clinical Evidence Actually Shows

Rigorous head-to-head RCTs comparing He Shou Wu to finasteride or minoxidil don't exist yet. What does exist: a meta-analysis of 30 RCTs (2,615 patients) comparing TCM herbal formulas — most including He Shou Wu — against conventional medicine found a total efficacy rate odds ratio of 3.34 (95% CI 2.75–4.05) favoring TCM, with significant reductions in symptom scores and no significant increase in adverse events [11][12]. He Shou Wu isn't isolated as monotherapy in these trials, so attribution is imprecise.

Preclinical data are stronger. In cultured human DPC spheroids, PM extract reversed DHT-induced receptor up-regulation and restored normal spheroid morphology [1]. Animal models showed measurable anagen induction. None of this is sufficient to claim equivalence with finasteride, but it's also not folklore.

If you're evaluating structured, clinician-supervised options that incorporate evidence-based botanicals alongside proven therapies, Hims's hair-loss platform offers combination protocols worth comparing.

The Liver Risk Is Not Optional Reading

He Shou Wu causes immune-mediated idiosyncratic drug-induced liver injury (DILI). This is documented, not theoretical. Cases have occurred with both raw and processed (Zhì hé shǒu wū) forms, at doses within traditional pharmacopoeial guidelines [3][6]. Emodin and physcion metabolites can deplete hepatic glutathione, inhibit bile-acid efflux transporters, and trigger mitochondrial dysfunction [6]. Rare but confirmed cases of acute liver failure have been reported.

The practical implication: He Shou Wu is not a supplement you add casually. Baseline liver enzymes and periodic monitoring are reasonable precautions. It should not be combined with other hepatotoxic agents. Anyone with pre-existing liver conditions should avoid it.

For a direct comparison of botanical approaches versus established topical therapies, see our editorial on deoxyribose gel vs. minoxidil for hair loss in men.

---

Related reading

• Deoxyribose Gel vs Minoxidil for Hair Loss in Men: What the Research Shows in 2026

Frequently asked questions

Does He Shou Wu actually regrow hair, or just slow shedding?

He Shou Wu appears to do both, though the evidence for regrowth is stronger in animal models than in human RCTs to date. Preclinical data show anagen induction via Wnt/β-catenin activation, while clinical TCM meta-analyses report improved total efficacy rates compared to conventional treatment [1]. Most practitioners report that reduced shedding becomes noticeable within 4–6 weeks, with visible density changes requiring 3–6 months of consistent use.

Is processed He Shou Wu (Zhì hé shǒu wū) safer than raw?

Processed He Shou Wu carries lower concentrations of the most acutely toxic anthraquinone fractions, but documented DILI cases have occurred with both forms [3][6]. Processing reduces — it does not eliminate — hepatotoxic risk. Liver enzyme monitoring is advisable regardless of which form is used, and the herb should be avoided entirely in individuals with hepatic compromise.

How does He Shou Wu compare to finasteride for androgenetic alopecia?

Finasteride has two decades of RCT data showing roughly 80–90% stabilization and meaningful regrowth in AGA [5]; He Shou Wu has strong mechanistic rationale and supportive preclinical evidence but no equivalent large-scale human trial data. The two act through different primary mechanisms — finasteride reduces systemic DHT production, while PM appears to attenuate androgen receptor